Health Care & Hospital Law,
Civil Litigation
Jun. 24, 2021
Federal jury rejects consumer class action against CVS over drug prices
The plaintiffs sought $121 million in damages, according to a published news report. The jury took just one day to deliver a verdict.
A federal jury ruled in favor of CVS Health on Wednesday in a class action brought by consumers who claimed they were overcharged for generic drugs. The plaintiffs sought $121 million in damages, according to a published news report.
The jury took just one day to deliver a verdict. The trial began June 8, according to court records. U.S. District Judge Yvonne Gonzalez Rog...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law, Civil Litigation
No evidence promotion increases opioid use, economist testifies
Jun. 30, 2021
By Blaise Scemama
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Most opioid addicts had history of drug abuse, doctor testifies
Jul. 1, 2021
By Blaise Scemama
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Former J&J medical consultant testifies in OC opioid trial
Jul. 7, 2021
By Blaise Scemama
By Blaise Scemama
